M
Murugan
About Murugan
Data last updated:
Murugan is a Director at Jms Healthcare Private Limited (since 2014). The companies operate in Trading and Chemicals. Jms Healthcare Private Limited reported revenue of ₹1.46 Cr (FY 2025). Earlier, Murugan was a Director at Anushoam Pharmaceuticals Private Limited (2018–2022) and Director at Jms Pharmaceutical Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Mar 2014 | 2014 | ₹1.46 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Nov 2018 | 2016 | ₹1.44 Cr (FY 2018) | Active | |
| Director | 25 Jan 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Murugan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bethu Naidu Senthil | 03325330 | Jms Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Murugan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Murugan
Murugan currently holds 1 directorship: Jms Healthcare Private Limited (Director, since 28 Mar 2014, revenue ₹1.46 Cr (FY 2025)).
Murugan was first appointed on 25 Jan 2011 as Director at Jms Pharmaceutical Private Limited. The most recent appointment on record is 14 Nov 2018 at Anushoam Pharmaceuticals Private Limited.
Murugan held 2 earlier board appointments: Anushoam Pharmaceuticals Private Limited (Director, 14 Nov 2018 to 20 Jul 2022); Jms Pharmaceutical Private Limited (Director, from 25 Jan 2011).
The current boards of Murugan's companies include Bethu Naidu Senthil (Jms Healthcare Private Limited).